T

Tarsus Pharmaceuticals

Develops FDA-approved ophthalmic therapies

Scientist – Pharmacology

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeIrvine, CA, USA

About the Job

Requirements

  • An advanced degree in pharmacology, biology, toxicology, biomedical sciences, or a related life-sciences field with at least 3 years of experience, or a bachelor’s or master’s degree with at least 5 years of experience.
  • Relevant pharmaceutical, biotechnology, academic, or contract-research experience supporting in vitro and in vivo research using molecular, cellular, or biochemical approaches to elucidate mechanism of action, target identification, or compound screening.
  • Ability to review scientific literature, protocols, data, reports, and technical documentation and translate findings into clear, actionable conclusions.
  • Strong organizational and project-management skills to manage multiple studies, vendors, deliverables, and priorities.
  • Excellent written and verbal communication skills, including preparing scientific reports, presentations, and regulatory-supporting documentation.
  • Strong interpersonal, collaboration, and influencing skills within multidisciplinary, matrixed teams.
  • Ability to work independently, with scientific curiosity and attention to detail, and to recognize when to seek input or escalate issues.
  • Enterprise and entrepreneurial mindset.

Responsibilities

  • Plan, coordinate, and execute nonclinical in vitro and in vivo studies supporting efficacy, mechanism of action, and proof of concept for program and therapeutic objectives.
  • Serve as a key knowledge holder for assigned programs, contributing scientific expertise in mechanism of action, study design, data interpretation, and risk assessment.
  • Lead day-to-day scientific and operational execution of outsourced studies, including developing and managing contract research organization contracts, work orders, scopes of work, budgets, schedules, deliverables, and study timelines.
  • Coordinate test-article and active pharmaceutical ingredient supply, sample shipment and tracking, and in-life study monitoring with contract research organizations and internal partners.
  • Review study protocols, amendments, data packages, and final reports for scientific quality, appropriate interpretation, and alignment with program needs.
  • Analyze, summarize, and communicate study findings through written reports, graphical summaries, presentations, and cross-functional team discussions.
  • Author, review, and quality-control nonclinical study reports and source content for regulatory documents and agency-interaction materials, including pre-investigational new drug, investigational new drug, new drug application, and Type B meeting briefing materials.
  • Support both non-good laboratory practice and good laboratory practice pivotal studies, working with internal teams and external partners to ensure completion in accordance with applicable requirements and program timelines.
  • Partner with Translational Science, Toxicology, Clinical Development, Regulatory Affairs, Chemistry, Manufacturing, and Controls, and Program Management to support integrated development plans and key decision points.
  • Maintain high standards of scientific rigor, data integrity, documentation, and study reproducibility.

Desired Qualifications

  • Experience planning, executing, overseeing, or interpreting nonclinical studies, including work performed through external contract research organizations or laboratory partners.
  • Knowledge of mechanism-of-action studies, disease models, pharmacodynamic endpoints, or translational biomarker approaches.
  • Experience in ophthalmology, dermatology, or related therapeutic areas.
  • Experience supporting programs from discovery through early development.

About the Company

Tarsus Pharmaceuticals

Develops FDA-approved ophthalmic therapies

Tarsus Pharmaceuticals develops and markets treatments for eye care and infectious diseases, including XDEMVY (lotilaner ophthalmic solution 0.25%), an FDA-approved eye drop for Demodex Blepharitis. The product is applied as a medicated eye drop to kill Demodex mites and relieve eyelid inflammation. The company differentiates itself with a focused ocular/infectious-disease portfolio, an FDA-approved therapy, and active partnerships to expand its research and reach. Its goal is to address unmet medical needs, grow its product lineup through commercialization, and pursue new indications in eye care and infectious diseases.

Company size
201-500
Company stage
IPO
Headquarters
Irvine, CA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Tarsus Pharmaceuticals

See more jobs